|
| related topics |
| {product, market, service} |
| {product, liability, claim} |
| {operation, international, foreign} |
| {product, candidate, development} |
| {customer, product, revenue} |
| {competitive, industry, competition} |
| {cost, operation, labor} |
| {personnel, key, retain} |
| {property, intellectual, protect} |
| {acquisition, growth, future} |
| {control, financial, internal} |
| {regulation, change, law} |
|
|
Risks Relating to Our Company
A catastrophic event at our Norcross, Georgia facility would prevent us from producing many of our reagent products.
Unforeseen product performance problems could prevent us from selling the affected products or even result in a recall of previously-placed products.
Poor product performance could increase operating costs and result in the loss of current or future customers.
We are highly dependent on our senior management team and other key employees, and the loss of one or more of these employees could adversely affect our operations.
If customers delay integrating our instruments into their operations, our operating results could be negatively impacted.
Our business is concentrated in North America and in order to continue to successfully grow our business, we must expand sales of our products outside North America.
Our business is concentrated in North America and if current or new competitors in North America increase the competition based on price, our market share and gross margins may be negatively impacted.
Our operating results would be materially adversely impacted if we are unable to maintain compliance with regulatory requirements.
The failure to successfully complete acquisitions and integrate them into our existing operations could adversely affect our financial results.
Because we sell our products internationally, we could be adversely affected by fluctuations in foreign currency exchange rates.
Our financial performance is highly dependent on the timely and successful introduction of new products and services.
We are dependent on some single source suppliers.
We may be unable to adequately protect our proprietary technology.
Risks Relating to our Industry
Government regulation may delay or prevent new product introduction and affect our ability to continue manufacturing and marketing existing products.
The industry and market segment in which we operate are highly competitive, and we may not be able to compete effectively with larger companies with greater financial resources than we have.
We may be exposed to product liability claims resulting from the use of products we sell and distribute.
Full 10-K form ▸
|
|
| related documents |
| 834306--3/16/2006--BIOSITE_INC |
| 736822--7/27/2007--IMMUCOR_INC |
| 736822--8/1/2006--IMMUCOR_INC |
| 1270597--3/23/2007--MERISANT_CO |
| 880432--9/26/2008--MISONIX_INC |
| 780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 28626--9/13/2007--LIFECORE_BIOMEDICAL_INC |
| 65270--7/1/2010--METHODE_ELECTRONICS_INC |
| 27096--9/13/2006--DATASCOPE_CORP |
| 1006195--3/15/2007--MATRIXX_INITIATIVES_INC |
| 880432--9/28/2009--MISONIX_INC |
| 771252--3/8/2006--DIGITAL_ANGEL_CORP |
| 922612--8/14/2008--SCHMITT_INDUSTRIES_INC |
| 718924--12/27/2006--SPAN_AMERICA_MEDICAL_SYSTEMS_INC |
| 1270597--3/31/2006--MERISANT_CO |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 1006045--4/10/2008--IRIDEX_CORP |
| 911160--6/2/2010--RF_MICRO_DEVICES_INC |
| 27096--9/12/2007--DATASCOPE_CORP |
| 108772--2/15/2008--XEROX_CORP |
| 886530--3/17/2008--DATATRAK_INTERNATIONAL_INC |
| 732026--9/25/2006--TRIO_TECH_INTERNATIONAL |
| 1000228--3/10/2006--SCHEIN_HENRY_INC |
| 1000228--2/26/2008--HENRY_SCHEIN_INC |
| 780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 28626--9/13/2006--LIFECORE_BIOMEDICAL_INC |
| 1034670--2/23/2007--AUTOLIV_INC |
| 876167--2/10/2006--PROGRESS_SOFTWARE_CORP_/MA |
| 716643--8/29/2008--REGIS_CORP |
| 108772--2/21/2006--XEROX_CORP |
|